All In MedTech

Device Trial Radar · NCT03126994

Prospective, Single-Center, Non-Randomized Study of the PhysioWave™ Cardiovascular Analyzer

Last checked: Nov 19, 2026Latest source record: Aug 31, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

160

Actual

Start

Apr 11, 2017

Primary completion

May 19, 2017

Study completion May 19, 2017

Sponsor

Lead sponsor
PhysioWave, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 25, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a prospective, single-center, non-randomized validation study being conducted under a non-significant risk study design with the primary aim to evaluate PWV, PR, and BW accuracy in a sample of subjects representative of the US general adult population. The primary study objective is to demonstrate equivalency when measuring: Pulse Wave Velocity (PWV) and Pulse Rate (PR) between the PhysioWave Cardiovascular Analyzer (CA) and AtCor Medical SphygmoCor® XCEL PWA \& PWV (XCEL), and Body Weight (BW) between the CA and the Detecto Solo Digital Healthcare Scale (Detecto).

Conditions

  • Cardiovascular Risk Factor

Interventions

  • PhysioWave Cardiovascular AnalyzerDevice

    Measurement of Pulse Wave Velocity, Pulse Rate, Body Weight and BMI

  • AtCor XCEL PWA & PWVDevice

    Measurement of Pulse Wave Velocity and Pulse Rate

  • Detecto SOLODevice

    Measurement of Body Weight and BMI

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Objective: PWV EquivalenceTime frame: Day 1
  2. Pulse Rate EquivalenceTime frame: Day 1
  3. Body Weight EquivalenceTime frame: Day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Diablo Clinical Research

    Walnut Creek, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.